John W.M. Claud

Reports Document FDA Review Delays: What Drugmakers Should Know Now

While FDA Suffers Staffing Cuts, Nondelegation Case In SCOTUS Is Latest Legal Challenge To Curb Agency Powers

In Uncertain Times, Good Compliance And Quality Communication Habits Can Offer A Port In The Storm

FOIA Requires Transparency Of Instructions To FDA Staff, Even When Those Instructions Are To Pause Communications With The Public

What We're Watching For In The Senate Confirmation Hearings To Consider Robert F. Kennedy, Jr. To Be Secretary Of HHS

GAO Report Recommends Retaining FDA's Drug Inspectional Workforce As Agency Prepares For Trumpian Changes

From The Porcine To The Ridiculous To The Court Of Appeals: Phibro's Suit Against FDA Gets Muddy

As Jurisprudence Under Loper Bright Develops, Early Scorecard Is Mixed

Homeopathic Industry Group Wants Court To Exclude It From FDA's Enforcement Plans

CDER's Office Of Compliance Kicks Off Annual Report Season With Rundown Of 2023's Major Public Health Enforcement Initiatives